2014-2026 Global Non-Invasive Prenatal Testing Devices Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for Non-Invasive Prenatal Testing Devices is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Companies Covered
Berry Genomics
Safembryo
Laboratory Corporation of America Holdings
Ariosa Diagnostics (Roche)
Sequenom
CombiMatrix
Agilent Technologies, Inc
Genpharm Services
Quest Diagnostics
California, Inc
LifeCodexx AG
PerkinElmer, Inc
F. Hoffmann-La Roche
Illumina, Inc
Koninklijke Philips N.V
Thermo Fisher Scientific, Inc
Sengenics
NIPD Genetics
GE Healthcare
LifeLabs Genetics
Premaitha Health PLC
Natera
Beijing Genomics Institute
QIAGEN N.V
Major Types Covered
Panorama Test
MaterniT21 Plus Test
Harmony Test
NIFTY Test
Verifi Test
IONA Test
Prena Test
Veracity Test
Major Applications Covered
Hospitals
Clinics
Research Laboratories
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
2019
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
Berry Genomics
Safembryo
Laboratory Corporation of America Holdings
Ariosa Diagnostics (Roche)
Sequenom
CombiMatrix
Agilent Technologies, Inc
Genpharm Services
Quest Diagnostics
California, Inc
LifeCodexx AG
PerkinElmer, Inc
F. Hoffmann-La Roche
Illumina, Inc
Koninklijke Philips N.V
Thermo Fisher Scientific, Inc
Sengenics
NIPD Genetics
GE Healthcare
LifeLabs Genetics
Premaitha Health PLC
Natera
Beijing Genomics Institute
QIAGEN N.V
Major Types Covered
Panorama Test
MaterniT21 Plus Test
Harmony Test
NIFTY Test
Verifi Test
IONA Test
Prena Test
Veracity Test
Major Applications Covered
Hospitals
Clinics
Research Laboratories
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.